Natural history of COVID-19 and therapeutic options
P Gautret, M Million, PA Jarrot… - Expert review of …, 2020 - Taylor & Francis
Introduction: COVID-19 presents benign forms in young patients who frequently present with
anosmia. Infants are rarely infected, while severe forms occur in patients over 65 years of …
anosmia. Infants are rarely infected, while severe forms occur in patients over 65 years of …
Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
Background The coronavirus disease 2019 (COVID‐19) pandemic has resulted in
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …
Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis
Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ …
respiratory tract infection, which can induce respiratory failure and multiple organ …
[HTML][HTML] RETRACTED: Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: An estimate
A Pradelle, S Mainbourg, S Provencher, E Massy… - 2024 - Elsevier
Following publication, the Journal was made aware of readers' debate about this article. The
Journal received a number of Letters to the Editor and correspondence from readers. The …
Journal received a number of Letters to the Editor and correspondence from readers. The …
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been
suggested as promising agents against the new coronavirus SARS-CoV-2 that induces …
suggested as promising agents against the new coronavirus SARS-CoV-2 that induces …
Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study
G Li, Y Liu, X **g, Y Wang, M Miao, L Tao… - Aging (Albany …, 2020 - pmc.ncbi.nlm.nih.gov
The COVID-19 pandemic causes severe morbidity and mortality. This multi-country study
aimed to explore risk factors that drive mortality in COVID-19 patients who received neither …
aimed to explore risk factors that drive mortality in COVID-19 patients who received neither …
The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium
FS Taccone, N Van Goethem, R De Pauw… - The Lancet Regional …, 2021 - thelancet.com
Background Several studies have investigated the predictors of in-hospital mortality for
COVID-19 patients who need to be admitted to the Intensive Care Unit (ICU). However, no …
COVID-19 patients who need to be admitted to the Intensive Care Unit (ICU). However, no …
Chloroquine and hydroxychloroquine for the prevention and treatment of COVID-19: A fiction, hope or hype? An updated review
In December 2019, the novel coronavirus disease pandemic (COVID-19) that began in
China had infected so far more than 109,217,366 million individuals worldwide and …
China had infected so far more than 109,217,366 million individuals worldwide and …
[HTML][HTML] High SARS-CoV-2 seroprevalence in healthcare workers in Bukavu, eastern Democratic Republic of Congo
D Mukwege, AK Byabene, EM Akonkwa… - The American Journal …, 2021 - ncbi.nlm.nih.gov
Among 359 healthcare workers (HCW) employed in Panzi General Referral Hospital located
in Bukavu in the Democratic Republic of Congo, 148 (41.2%) tested positive for SARS-CoV …
in Bukavu in the Democratic Republic of Congo, 148 (41.2%) tested positive for SARS-CoV …
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
Covid-19 is an infectious respiratory disease due to a coronavirus named SARS-CoV-2. A
critical step of the infection cycle is the binding of the virus spike S protein to the cellular ACE …
critical step of the infection cycle is the binding of the virus spike S protein to the cellular ACE …